These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27689398)

  • 1. Comparative effectiveness of image-guided radiotherapy for non-operated localized esophageal squamous cell carcinoma patients receiving concurrent chemoradiotherapy: A population-based propensity score matched analysis.
    Li CC; Chen CY; Chien CR
    Oncotarget; 2016 Nov; 7(44):71548-71555. PubMed ID: 27689398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis.
    Chen CY; Li CC; Chien CR
    Radiother Oncol; 2016 Jul; 120(1):136-9. PubMed ID: 27207358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy.
    Kuo YH; Fang HY; Lin YS; Lein MY; Yang CY; Ho SC; Li CC; Chien CR
    Thorac Cancer; 2020 Jan; 11(1):113-119. PubMed ID: 31742897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intensity-modulated radiotherapy vs 3-dimensional conformal radiotherapy for patients with non-metastatic esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy: A population-based propensity-score-matched analysis.
    Li CC; Chen CY; Chien CR
    Medicine (Baltimore); 2018 Jun; 97(22):e10928. PubMed ID: 29851829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of image-guided radiotherapy for rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy: A population-based propensity score-matched analysis.
    Li CC; Liang JA; Chen WT; Chien CR
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e197-e203. PubMed ID: 31250970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
    Chen CY; Li CC; Chien CR
    World J Surg Oncol; 2018 Jul; 16(1):141. PubMed ID: 30007409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of image-guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy.
    Liang JA; Tu CY; Hsia TC; Fang HY; Li CC; Chien CR
    Thorac Cancer; 2020 Sep; 11(9):2639-2649. PubMed ID: 32725779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
    Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
    Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis.
    Zhang P; Xi M; Li QQ; Hu YH; Guo X; Zhao L; Liu H; Liu SL; Luo LL; Liu Q; Liu MZ
    Oncotarget; 2016 Jul; 7(28):44686-44694. PubMed ID: 27183916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study.
    Chen WM; Yu YH; Chen M; Shia BC; Wu SY
    J Thorac Oncol; 2023 Aug; 18(8):1082-1093. PubMed ID: 37085031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose.
    Li CC; Fang HY; Lin CY; Shen WC; Chien CR
    Anticancer Res; 2019 Jan; 39(1):511-517. PubMed ID: 30591503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae.
    Ma L; Luo GY; Ren YF; Qiu B; Yang H; Xie CX; Liu SR; Liu SL; Chen ZL; Li Q; Fu JH; Liu MZ; Hu YH; Ye WF; Liu H
    Chin J Cancer; 2017 Jan; 36(1):8. PubMed ID: 28077159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
    Lin WC; Ding YF; Hsu HL; Chang JH; Yuan KS; Wu ATH; Chow JM; Chang CL; Chen SU; Wu SY
    Cancer; 2017 Oct; 123(20):3904-3915. PubMed ID: 28608916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients.
    Liu A; Wang Y; Wang X; Zhu L; Nie Y; Li M
    Radiat Oncol; 2021 Oct; 16(1):195. PubMed ID: 34600574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.
    Chang CL; Tsai HC; Lin WC; Chang JH; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
    Radiother Oncol; 2017 Oct; 125(1):73-79. PubMed ID: 28923576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consolidative chemotherapy after definitive concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients: a population based cohort study.
    Lin CY; Lien MY; Chen CC; Fang HY; Lin YS; Chen CK; Chen JX; Lu TY; Huang TM; Hsieh TC; Sun SS; Li CC; Chien CR
    BMC Gastroenterol; 2022 Aug; 22(1):381. PubMed ID: 35948871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma.
    Ren X; Wang L; Han C; Ren L
    Radiother Oncol; 2018 Nov; 129(2):293-299. PubMed ID: 30270099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis.
    Song T; Du D; Zhang X; Fang M; Wu S
    Dis Esophagus; 2017 Sep; 30(9):1-10. PubMed ID: 28859362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study.
    Li CC; Chen CY; Chou YH; Huang CJ; Ku HY; Chien CR
    BMC Gastroenterol; 2021 Apr; 21(1):153. PubMed ID: 33827451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal radiotherapy dose in cervical esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy: A population based study.
    Li CC; Chen CY; Chou YH; Huang CJ; Ku HY; Chien CR
    Thorac Cancer; 2021 Jul; 12(14):2065-2071. PubMed ID: 34028200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.